Bringing you the latest pharmaceutical industry news, views and opinion.
Drug Discovery & Development (DDD) is part of the Pharma Press portfolio and welcomes readers, partners, contributors to join it’s innovative and vibrant community.
The mission of Drug Discovery & Development (DDD) is to advance scientific innovation into active medical solutions.
This mission is driven by preclinical scientific innovation, ethical responsibility and collaboration among academia, research organisations industry partners.
Sharing the progress of research, scientific discoveries, the challenges and the varied avenues to success, combined with evidence-led insights, industry and technological developments, DDD aims to advance the progress of medical breakthroughs in human diseases and improve healthcare worldwide.
Through the engagement of discussion and shared insights among industry professionals, DDD aims to stimulate and forge meaningful partnerships, investment and collaborations to accelerate the transition from preclinical to drug development and through successful clinical trials.
Structured with vision and purpose, DDD aims to inform, enlighten and progress readers’ innovation and success.
DDD brings a unique insight into biologics innovation and development from core therapeutic areas to biomanufacturing and bioprocessing to analysis and molecular discoveries.
DDD discusses new insights in research, diagnosis and process, to unlocking innovations to inspire, evolve and drive progress in drug discovery and development.
DDD is a quarterly digital title and monthly newsletter, with an up-to-date targeted database.
https://www.pharmapress.co.uk/
https://linkedin.com/showcase/drug-discovery-and-development/
https://x.com/pharma_press
https://www.facebook.com/profile.php?id=61583319311466
